KPV

Approved source records

1. A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon.

   Zhao Y, Xue P, Lin G, Tong M, Yang J, Zhang Y, Ran K, Zhuge D, Yao Q, Xu H. · 2022

   DOI: 10.1016/j.actbio.2022.02.039PMID: 35245681

2. Self-Cross-Linked Hydrogel of Cysteamine-Grafted γ-Polyglutamic Acid Stabilized Tripeptide KPV for Alleviating TNBS-Induced Ulcerative Colitis in Rats.

   Sun J, Xue P, Liu J, Huang L, Lin G, Ran K, Yang J, Lu C, Zhao YZ, Xu HL. · 2021

   DOI: 10.1021/acsbiomaterials.1c00792PMID: 34547895

3. Are melanocortin peptides future therapeutics for cutaneous wound healing?

   Böhm M, Luger T. · 2019

   DOI: 10.1111/exd.13887PMID: 30661264

4. Peptide Receptor-Targeted Fluorescent Probe: Visualization and Discrimination between Chronic and Acute Ulcerative Colitis.

   Zeng M, Shao A, Li H, Tang Y, Li Q, Guo Z, Wu C, Cheng Y, Tian H, Zhu WH. · 2017

   DOI: 10.1021/acsami.7b00936PMID: 28349696

5. Synthesis and characterization of time-resolved fluorescence probes for evaluation of competitive binding to melanocortin receptors.

   Alleti R, Vagner J, Dehigaspitiya DC, Moberg VE, Elshan NG, Tafreshi NK, Brabez N, Weber CS, Lynch RM, Hruby VJ, Gillies RJ, Morse DL, Mash EA. · 2013

   DOI: 10.1016/j.bmc.2013.06.052PMID: 23890524

6. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.

   Laroui H, Dalmasso G, Nguyen HT, Yan Y, Sitaraman SV, Merlin D. · 2010

   DOI: 10.1053/j.gastro.2009.11.003PMID: 19909746

7. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.

   Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. · 2008

   DOI: 10.1053/j.gastro.2007.10.026PMID: 18061177

8. Structure-function relationships and conformational properties of alpha-MSH(6-13) analogues with candidacidal activity.

   Carotenuto A, Saviello MR, Auriemma L, Campiglia P, Catania A, Novellino E, Grieco P. · 2007

   DOI: 10.1111/j.1747-0285.2007.00473.xPMID: 17313459

9. Three-dimensional structure of the alpha-MSH-derived candidacidal peptide [Ac-CKPV]2.

   Catania A, Grieco P, Randazzo A, Novellino E, Gatti S, Rossi C, Colombo G, Lipton JM. · 2005

   DOI: 10.1111/j.1399-3011.2005.00265.xPMID: 15946192

10. Novel alpha-melanocyte stimulating hormone peptide analogues with high candidacidal activity.

    Grieco P, Rossi C, Colombo G, Gatti S, Novellino E, Lipton JM, Catania A. · 2003

    DOI: 10.1021/jm0204338PMID: 12593664

11. Changes in glucocorticoid and mineralocorticoid receptors of liver and kidney cytosols after pathologic stress and its regulation in rats.

    Liu DH, Su YP, Zhang W, Lu SF, Ran XZ, Gao JS, Cheng TM. · 2002

    DOI: 10.1097/00003246-200203000-00022PMID: 11990926

12. Characterization of melanocortin NDP-MSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors.

    Haskell-Luevano C, Holder JR, Monck EK, Bauzo RM. · 2001

    DOI: 10.1021/jm010061nPMID: 11405661

13. Conformational analysis of tripeptide Ac-Lys-Pro-Val-NH2, COOH-terminal sequence of alpha-MSH.

    Chavatte P, Yous S, Lesieur D, Hénichart JP. · 2001

    DOI: 10.1211/0022357011776360PMID: 11480545

14. [Changes in aldosterone binding activity of kidney cytosol after stress in rats and the regulation].

    Liu DH, Su YP, Zhang W, Lou SF, Gao JS, Cheng TM. · 2001

    PMID: 11833422

15. Solution structures of the melanocyte-stimulating hormones by two-dimensional NMR spectroscopy and dynamical simulated-annealing calculations.

    Lee JH, Lim SK, Huh SH, Lee D, Lee W. · 1998

    DOI: 10.1046/j.1432-1327.1998.2570031.xPMID: 9799099

16. Characterizations of the unusual dissociation properties of melanotropin peptides from the melanocortin receptor, hMC1R.

    Haskell-Luevano C, Miwa H, Dickinson C, Hadley ME, Hruby VJ, Yamada T, Gantz I. · 1996

    DOI: 10.1021/jm950407sPMID: 8558511

17. Truncation studies of alpha-melanotropin peptides identify tripeptide analogues exhibiting prolonged agonist bioactivity.

    Haskell-Luevano C, Sawyer TK, Hendrata S, North C, Panahinia L, Stum M, Staples DJ, Castrucci AM, Hadley MF, Hruby VJ. · 1996

    DOI: 10.1016/0196-9781(96)00141-6PMID: 8899819

18. Antiinflammatory influences of alpha-MSH molecules: central neurogenic and peripheral actions.

    Macaluso A, McCoy D, Ceriani G, Watanabe T, Biltz J, Catania A, Lipton JM. · 1994

    DOI: 10.1523/JNEUROSCI.14-04-02377.1994PMID: 8158274

19. Binding of anti-inflammatory alpha-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells.

    Lyson K, Ceriani G, Takashima A, Catania A, Lipton JM. · 1994

    DOI: 10.1159/000097145PMID: 7489322

20. Peripheral analgesic activities of peptides related to alpha-melanocyte stimulating hormone and interleukin-1 beta 193-195.

    Poole S, Bristow AF, Lorenzetti BB, Das RE, Smith TW, Ferreira SH. · 1992

    DOI: 10.1111/j.1476-5381.1992.tb14361.xPMID: 1327383

21. Design of potent linear alpha-melanotropin 4-10 analogues modified in positions 5 and 10.

    Al-Obeidi F, Hruby VJ, Castrucci AM, Hadley ME. · 1989

    DOI: 10.1021/jm00121a032PMID: 2535874

22. Cyclic melanotropins. 5. Importance of the C-terminal tripeptide (Lys-Pro-Val).

    Cody WL, Wilkes BC, Muska BJ, Hruby VJ, Castrucci AM, Hadley ME. · 1984

    DOI: 10.1021/jm00375a018PMID: 6332195

23. Largomycin: preparation, properties, and structure.

    Vandré DD, Zaheer A, Squier S, Montgomery R. · 1982

    DOI: 10.1021/bi00263a037PMID: 7138848

24. [half-Cys4,half-Cys10]-alpha-Melanocyte-stimulating hormone: a cyclic alpha-melanotropin exhibiting superagonist biological activity.

    Sawyer TK, Hruby VJ, Darman PS, Hadley ME. · 1982

    DOI: 10.1073/pnas.79.6.1751PMID: 6281785

25. Melanotropic peptides: presence in brain of normal and hypophysectomized rats, and subcellularly localized in synaptosomes.

    Loh YP, Zucker L, Verspaget H, Van Wimersma Greidanus TB. · 1979

    DOI: 10.1002/jnr.490040208PMID: 229237